therapeutic 4,341 words KG: ent-dise-bfd8f32d 2026-03-24
section:therapeuticskind:therapeutictopic:cbstopic:psptopic:roboticstopic:assistive-devicestopic:rehabilitation-technologytopic:exoskeletontopic:smart-hometopic:augmentative-communication
Contents

Section 152: Advanced Robotics and Assistive Devices in CBS/PSP

💊 Therapeutic Info
NameSection 152: Advanced Robotics and Assistive Devices in CBS/PSP
SummaryRobotics-assisted rehabilitation (exoskeletons, gait trainers, robotic arms), assistive devices for ADLs (adaptive utensils, dressing aids, communication devices), powered wheelchairs, smart home integration for CBS/PSP patients, device specifications, training requirements, cost considerations

Knowledge Graph

Related Hypotheses (16)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Purinergic Signaling Polarization Control
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51

Related Analyses (7)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (14)

Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40

See Also (15)

A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 7 hypotheses
A Phase IIB, Randomized, Double-Blind, Placebo-Controll
clinical · Pages share 7 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 7 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
WNK1 Kinase in Neurodegeneration
mechanism · Pages share 6 hypotheses